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The purpose of this study was to investigate the use of antibiotic prophylaxis for plastic surgical pro-
cedures at our hospital, and to perform a systematic literature review of randomized controlled trials
evaluating the use of prophylactic antibiotics in plastic surgery. The records of patients who received
plastic surgical procedures with Class I surgical incisions between 2009 and 2010 were retrospectively
reviewed. A systematic literature review was conducted for studies examining the use of prophylactic
antibiotics for Class I surgical wounds. A total of 13,997 cases with Class I surgical incisions were
included. Prophylactic antibiotics were given in 13,865 cases (99.1%). The antibiotics used were primarily
cefuroxime, clindamycin, metronidazole, cefoxitin sodium, and gentamicin. The average duration of
administration was 4.84 ± 3.07 (range, 1e51) days. Antibiotics were administered postoperatively in
>99% of cases while preoperative antibiotic administration was only given in 32 cases (0.23%). Wound
infections occurred in 21 cases for an overall infection rate of 0.15%. Fourteen studies met the inclusion
criteria of the systematic review. There was marked variation in the timing of antibiotic administration
with antibiotics given pre-, peri-, and postoperatively. Of studies that compared the use of prophylactic
antibiotics with placebo, a reduction in wound infections was noted in 4 trials and no difference was
noted in 6 trials. No signiﬁcant difference in infection rates was shown between the prophylactic and
postoperative arms. In conclusion, prophylactic antibiotics are overused in plastic surgical procedures.
Evidence-based guidelines for the use of prophylactic antibiotics in plastic surgical procedures are
needed.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.).
work.
by Elsevier Ltd. All rights reserved1. Introduction
Surgical site infections are deﬁned as infections that occur near
or at a surgical incision within 30 days of the surgery, and are a
major cause of morbidity in patients that have undergone surgery
[1]. Surgical antibiotic prophylaxis refers to the short-term.
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has clearly been shown to reduce the incidence of surgical site
infections [2]. Prophylaxis with antibiotics has been shown to be
effective in many procedures including gastrointestinal, oropha-
ryngeal, vascular, open heart, obstetric and gynecological, and or-
thopedic, and clear recommendations for their use have been
developed [1,2]. Because their use is preventative they are used in
operations in which minimal microbial contamination of the sur-
gical site is expected, e.g., clean Class I surgical wounds [1,2].
General principles of antibiotic prophylaxis indicate that the ﬁrst
dose should be given before the incision, the antibiotic should be
effective for the causative organism of the potential infection, a full
therapeutic dose should be administered, and antibiotics should be
continued no longer than 24 h after the procedure is completed
[1,3].
While clear guidelines have been established for antibiotic
prophylaxis in many surgical procedures, guidelines for their use in
plastic surgical procedures are lacking, and some experts consider
their use unwarranted in “clean” procedures because the rate of
infections is so low [1,2]. However, the use of prophylactic antibi-
otics in clean surgery is widespread and their timing of adminis-
tration and selection is often based on convention and personal and
local departmental preferences. There is also a tendency towards
excessive administration of antibiotics, and lack of sufﬁcient robust
evidence onwhich to base such decisions for antibiotic prophylaxis
in plastic surgery.
In 2004 Ministry of Health in China published the “Principles
and guidelines for clinical applications of prophylactic antibiotics”
[4]. In the wake of the long history of prophylactic antibiotics abuse
in China, the Ministry of Health published ofﬁcial guidelines for the
clinical use of prophylactic antibiotics in February 2012, titled:
“Principles of managing the clinical application of prophylactic
antibiotics” [5]. The guidelines were implemented in August 2012.
According to the regulations, prophylactic antibiotics are classiﬁed
into 3 categories: use without restriction, use with restriction, and
antibiotics used in special circumstances. When combined, there
should be no more than 2 antibiotics (intravenously or orally,
respectively) prescribed within the same group of prophylactic
antibiotics. Hospitals andmedical centers are required to record the
supply and usage of prophylactic antibiotics. Physicians are
required to refer to ofﬁcial guidelines for the application of pro-
phylactic antibiotics.
The guidelines state that for clean surgeries, antibiotics should
be given within ½ to 2 h prior to the procedure or with anesthesia
pre-medications, and that the effect of prophylactic antibiotics
should cover the duration of surgery and 4 h after the surgery, and
should not be administered for more than 24 h in total. Evaluation
of the rationality of prophylactic antibiotic therapy was carried out
according to the guidelines at our hospital, a center that special-
izes in plastic surgery, which are based on the guidelines above. It
was concluded that irrational application of prophylactic antibi-
otics includes: 1) A rate of prophylactic antibiotic application
>30%; 2) Administration of antibiotics for a duration of 24 h
<90%; 3) Antibiotics administered 1 day prior to surgery or only
postoperatively; and 4) The use of antibiotics without a clear
indication.
The purposes of this study were to 1) review the use of pro-
phylactic antibiotic at tertiary care medical center that performs
only plastic surgical procedures in the period preceding the
publication of the guidelines by the Ministry of Health, and 2) to
perform a systematic literature review of randomized controlled
trials (RCTs) examining the use of prophylactic antibiotics to
prevent surgical site infections (SSIs) in plastic surgical
procedures.2. Materials and methods
2.1. Clinical study
In this study, the medical records of patients who had plastic
surgery with Class I wounds from January 1, 2009 to December 31,
2010 at a tertiary care national medical center in which only plastic
surgical procedures are performed were retrospectively reviewed.
This study was approved by the Institutional Board of the Plastic
Surgery Hospital afﬁliated to the Chinese Academy of Medical Sci-
ences and Peking Union Medical College, and because of the
retrospective nature the requirement of patient informed consent
was waived.
Data extracted from the medical records included the patients'
name, gender, age, length of stay, primary diagnosis, primary sur-
gical procedure, surgeon, major surgical incision type, type of
healing, the occurrence of incisional infection, whether prophy-
lactic antibiotics were used, type of used antibiotics, duration of
antibiotic administration, method of antibiotic administration,
dosage, and timing of prophylactic antibody therapy.
A Class I/clean surgical wound was deﬁned according to the
Healthcare Infection Control Practices Advisory Committee (HIC-
PAC) Guideline for Prevention of Surgical Site Infection, 1999 [1].
Brieﬂy, a Class I wound was an uninfected operative wound in
which no inﬂammation was present and the respiratory, alimen-
tary, genital, or uninfected urinary tract was not entered. The
wound was closed primarily, and drained, if necessary, with closed
drainage. Operative incisional wounds following nonpenetrating
(blunt) traumawere included if the other criteria were met. Wound
healing was classiﬁed as primary, secondary, or tertiary intention
[6]. Primary healing was deﬁned as the wound edges approximated
and closed with sutures, staples, or adhesive tape. Secondary
healing was deﬁned as wound healing by granulation. Healing by
tertiary intention was deﬁned as initial debridement, observation
for 4e5 days, and then closure.2.2. Systematic literature review
A systematic literature review was conducted for studies
examining the use of prophylactic antibiotics for Class I surgical
wounds. A search was conducted of Medline, Cochrane, EMBASE,
and Google Scholar on July 31, 2013 using combinations of the
following keywords: prophylactic antibiotics/agents, antimicrobial
prophylaxis, antibiotic prophylaxis, antibiotics, plastic surgery, and
reconstructive surgery. Inclusion criteria were 1) randomized
controlled trial; 2) examined the use of prophylactic antibiotics
pre-, peri-, or post-operatively in surgical cases with Class I
wounds; 3) English language.
Studies were identiﬁed by the search strategy by one reviewer.
A second reviewer extracted the following information/data from
studies that met the inclusion criteria: the name of the ﬁrst
author, year of publication, study design, number of participants
in each treatment group, participants' age, the type, dosage,
timing, and route of administration of the antibiotics, and the
results. The primary outcome of interest was the surgical site
infection rate.2.3. Statistical analysis
Data of prophylactic antibiotic use, surgical infections, and
wound healing by primary, secondary, and tertiary intentions were
summarized as number (percentage). Data were recorded and
analysis performed using Microsoft Ofﬁce Excel 2007.
Table 2
Organisms isolated in 2009 and 2010 from 21 cases of wound infections.
Organism Year 2009 Year 2010
No bacterial growth 1 (16.7%) 1 (9.1%)
Staphylococcus 1 (16.7%) 3 (27.2%)
Methicillin-resistant Staphylococcus aureus (MRSA) 0 (0%) 1 (9.1%)
Methicillin-sensitive Staphylococcus aureus (MSSA) 1 (16.7%) 0 (0%)
Pseudomonas aeruginosa 1 (16.7%) 1 (9.1%)
Coagulase-negative staphylococci 1 (16.7%) 0 (0%)
E. coli Gram-positive cocci 1 (16.7%) 0 (0%)
Hemolytic streptococcus 0 (0%) 1 (9.1%)
Klebsiella pneumoniae 0 (0%) 1 (9.1%)
Fungi 0 (0%) 1 (9.1%)
Methicillin resistant coagulase-negative
staphylococci (MRCNS)
0 (0%) 1 (9.1%)
Serratia marcescens 0 (0%) 1 (9.1%)
Note: Two patients in 2009 and 4 in 2010 did not have bacterial cultures performed.
One patient in 2009 had multiple positive culture results.
Table 3
Wound healing in 2009 and 2010.
Year Primary intention Secondary intention Tertiary intention
2009 6645 (99.9%) 8 (0.1%) 0 (0%)
2010 7340 (99.9%) 4 (0.1%) 0 (0%)
Total 13,985 (99.9%) 12 (0.1%) 0 (0%)
G.-h. Li et al. / International Journal of Surgery 12 (2014) 1300e130513023. Results
3.1. Clinical study
A total of 13,997 cases with Class I surgical incisions were
included in the study, and there were 7093 males and 6904 fe-
males. Prophylactic antibiotic administration was given in 13,865
cases (99.1%) (Table 1). A total of 9541 (68.81%) patients received
monotherapy, 3335 (24.05%) received a combination of 2 antibi-
otics, and 989 (7.13%) received a combination of 3 or more antibi-
otics. Antibiotics that were used with a frequency of more than 1%
were cefuroxime (50.7%), gentamicin (13.7%), metronidazole (6.1%),
clindamycin (5.4%), cefoxitin sodium (5.4%), ceﬁxime (4.5%), levo-
ﬂoxacin (3.9%), cefradine (2.9%), etimicin (1.7%), and cefaclor (1.2%).
Intravenous administration was given in 13,741 cases (99.1%). The
average duration of medication administration was 4.84 ± 3.07
days (range, 1e51 days). Antibiotics were administered for24 h in
<1% of all cases, and antibiotics were administered postoperatively
in >99% of cases. On the other hand, preoperative antibiotic
administration was only given in 32 cases (0.23%) and intra-
operative administration was only given in 9 cases (0.06%).
Of the 13,997 cases, wound infections occurred in 21 cases for an
overall infection rate of 0.15%. Methicillin-sensitive Staphylococcus
aureus (MSSA), methicillin-resistant coagulase-negative staphylo-
cocci (MRCNS), and S. aureus were the most common types of
bacteria identiﬁed from the patients with wound infections
(Table 2). Primary healing of the wound occurred in 13,985 cases
(99.9%), and secondary healing in 12 (0.1%) (Table 3).Fig. 1. Flow chart of study selection.3.2. Systematic literature review
A total of 214 studies were identiﬁed though the database
searches, and after excluding non-relevant studies and those that
did not meet the inclusion criteria, 14 were included in the review.
A ﬂowchart of study selection is shown in Fig. 1. The 14 studies
[7e20] included in the review are summarized in Table 4. Cepha-
losporins were the most commonly used antibiotics for prophy-
laxis, followed by amoxicillin preparations. There was marked
variation in the timing of antibiotic administration with antibiotics
given pre-, peri-, and postoperatively.
Of studies that compared the use of prophylactic antibiotics
with placebo (no antibiotics), a reduction in wound infections was
noted in 4 [8,18e20], and no difference was noted in 6
[7,10,12,14,16,17]. The results of one study [15] suggested that the
effect of prophylactic antibiotics on wound infections depends on
the types of surgery performed. Another study [13] showed no
infection with or without the use of prophylactic antibiotics. One
study designed for comparison between postoperative antibiotic
use (postoperative arm) and prophylactic plus postoperative anti-
biotic use (prophylactic arm)without placebo control [9]. Of studies
that compared the efﬁcacy of prophylactic with postoperative
antibiotic use, 4 out of 4 studies [8e10,12] suggested no signiﬁcantTable 1
Prophylactic antibiotic use for surgeries with class I incisions in 2009 and 2010.
Year Total cases Cases with antibiotic use Time of administration
Preoperativea Intraop
2009 6653 6608 (99.3) 15 (0.23) 6 (0.09
2010 7344 7257 (98.8) 17 (0.23) 3 (0.04
Total 13,997 13,865 (99.1) 32 (0.23) 9 (0.06
Data are presented as case (percentage).
a Antibiotics given ½ to 2 h prior to procedure.difference in infection rates between the prophylactic and post-
operative arms.
No signiﬁcant difference in infection rates was found in one
study11 that compared the efﬁcacy of intravenous and oral
administration.Duration of antibiotic
administration 24 h
Cases with
infection at incision
erative Postoperative
) 6587 (99.7) 5 (0.08) 6 (0.09)
) 7237 (99.7) 11 (0.15) 15 (0.2)
) 13,824 (99.7) 16 (0.12) 21 (0.15)
Table 4
Summary of randomized controlled trials for prophylactic antibiotic administration.
Ref. no. First author
(year)
Type of surgery Sample size Treatment Infection rate p-value
Antibiotic regimen I Antibiotic regimen II Control Treatment
duration
Regimen I Regimen II Control
[7] Ergul (2012) Elective inguinal
hernioplasty
200 Pre-, peri-: Cefazolin 1 g IV once
Post-: none
e Placebo e 5% e 7% p ¼ 0.38
[8] Sevin (2007) Abdominoplasty 207 Pre-, peri-: cephalosporin 1 g IV (alt
levoﬂoxacin 500 mg IV) once
Post-: none
Pre-, peri-: Cephalosporin 1 g
IV (alt levoﬂoxacin 500 mg IV)
once
Post-: cephalosporin 1 g IV (alt
levoﬂoxacin 500 mg IV) bid
No antibiotic 3 d 3% 3% 9% p < 0.05 for
regimen I, II
vs. control,
p > 0.05 for
regimen I vs. II
[9] Andrews (2006) Complex
septorhinoplasty
surgery (grafting and/or
revision surgery)
164 Pre-, peri-: none
Post-: amoxicillin-clavulanate
375 mg PO tid (alt erythromycin
500 mg PO qid)
Pre-, peri-: Amoxicillin-
clavulanate 1200 mg IV once
(alt erythromycin 1000 mg IV)
Post-: amoxicillin- clavulanate
1200 mg IV twice (6 and 12 h
after surgery) (alt erythromycin
1000 mg IV)
e 7 d 7% 11% e p ¼ 0.42
[10] Ahmadi (2005) Reduction
mammoplasty
50 Pre-, peri-: cefazolin 1 g IV (alt
levoﬂoxacin 500 mg IV) once
Post-: none
Pre-, peri-: cefazolin 1 g IV(alt
levoﬂoxacin 500 mg IV) once
Post-: cefazolin 1 g IV q8h for 2
doses, then cephalexin 500 mg
PO daily (alt levoﬂoxacin
500 mg PO daily)
No antibiotic 3 d 18% 25% 29% p > 0.91
[11] Kuzu (2005) Prosthetic inguinal
hernia repair
408 Pre-, peri-: amoxicillineclavulanic
acid 1.313 g PO once
Post-: none
Pre-, peri-: amoxicillin
eclavulanic acid 1.2 g IV once
Post-: none
e e 0.5% 1.5% e p > 0.05
[12] Whittaker (2005) Clean incised hand
injuries
157 pre-, peri-: Flucloxacillin 1 g IV
once
Post-: placebo 1 tablet PO qid
pre-, peri-: Flucloxacillin 1 g IV
once
Post-: ﬂucloxacillin 500 mg PO
qid
Placebo 5 d 13% 4% 15% p ¼ 0.19
(for all)
[13] Chow (2000) Mastectomy 54 Pre-, peri-: clarithromycin 500 mg
PO twice daily
Post-: clarithromycin 500 mg PO
twice daily
e No antibiotic 4 d 0% e 0% N/A
[14] Gupta (2000) Clean elective breast
surgery
351 Pre-, peri-: augmentin 1.2 g IV once
Post-: none
e Placebo e 17.7% e 18.8% p ¼ 0.79
[15] Platt (1990) Herniorrhaphy 612 Pre-, peri-: cefonicid 1 g IV once
Post-: none
e Placebo e 2.3% e 4.2% p > 0.05
Breast surgery 606 Pre-, peri-: cefonicid 1 g IV once
Post-: none
e Placebo e 6.6% e 12.2% p < 0.05
[16] Baran (1999) Reconstruction because
of trauma or a tumor or
congenital abnormality
in the head neck region
400 Pre-, peri-: sulbactam- ampicillin
2 g IV once
Post-: none
e Placebo e 6.5% e 7.0% p > 0.05
Cosmetic surgery 300 Pre-, peri-: sulbactam- ampicillin
2 g IV once
Post-: none
e Placebo e 1.3% e 2.0% p > 0.05
Flapor graft procedure
for reconstruction of
trunk or extremity
defects
400 Pre-, peri-: sulbactam- ampicillin
2 g IV once
Post-: none
e Placebo e 6.0% e 5.0% p > 0.05
Alloplastic implants 300 Pre-, peri-: sulbactam- ampicillin
2 g IV once
Post-: none
e Placebo e 5.3% e 7.3% p > 0.05
Total 1400 Pre-, peri-: sulbactam- ampicillin
2 g IV once
Post-: none
e Placebo e 5.0% e 5.4% p > 0.05
(continued on next page)
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The results of the clinical study showed that the administration
of prophylactic antibiotics for plastic surgical procedures at our
hospital are not in line with the guidelines for antibiotic use
recently published by the Ministry of Health. Overall, antibiotics
were administered too frequently, the antibiotics administered
were not appropriate for the potential causative organisms, and the
timing and duration of administration were not appropriate. Re-
sults of the systematic review also indicated broad variation in the
antibiotic administered and in the timing and dosage administered.
In addition, in approximately 50% of the studies there was not
difference in the infection rate of patients inwhom antibiotics were
given prophylactically and those who did not receive antibiotics.
Though prophylactic use of antibiotics are recommended for
some surgical procedures, and the prophylactic effect of antibiotics
on surgical site infections is indisputable, antibiotic therapy is not
required for all surgeries [1,2,21]. The incidence of surgical site
infection is closely related to the cleanliness of the surgery itself.
Most surgeries are aseptic, the rate of postoperative infection is
about 2%, and themost commonly seen pathogens are S. aureus and
Staphylococcus epidermidis [1,2,22]. The range of antibiotic appli-
cation is relatively broad in plastic surgical procedures, and peri-
operative prophylactic antibiotic therapy is a powerful method for
preventing the postoperative infections, enhancing the safety of
surgery, and increasing the recovery rate [23]. In addition, antibi-
otics are clearly important for certain procedures inwhich although
the risk of infection is low, the results of an infection may be sig-
niﬁcant [24].
There have been other systematic reviews regarding the use of
prophylactic antibiotics in different reconstructive surgical pro-
cedures. Phillips et al. [25] reviewed antibiotic use in breast recon-
struction and found that the infection rates in patients receiving no
antibiotics, antibiotics for a duration<24 h, and for a duration>24 h
were 14.4%, 5.8%, and 5.8%, respectively. A recent CochraneDatabase
review by Bunn et al. [26] examining prophylactic antibiotics to
prevent surgical site infection after breast cancer surgery concluded
that antibiotics administered preoperatively reduce the risk of SSI in
this group of patients. In 2008 Tadiparthi [27] examined the evi-
dence for the use of prophylactic antibiotics in clean, non-implant
plastic surgery and concluded that while the use of antibiotics is
widespread their use is primarily based on convention and personal
preference and that there is insufﬁcient evidence on which to base
decisions to administer them.
While it may be argued that the use of prophylactic antibiotics
will “do no harm” and may prevent a SSI, the indiscriminate use of
antibiotics is harm-free. It is well known that broad-spectrum an-
tibiotics can lead to bacterial resistance and super-infection and
there is always a risk of allergic reaction. Abuse of antibiotics has
induced bacterial resistance on a global scale, making compliance
with guidelines for administration critical [28,29].
There are some limitations of this study that should be
considered. The clinical study was retrospective in nature, and an
analysis by type of surgical procedure was not performed. The re-
sults of the clinical study clearly showed there was not compliance
with the 2012 guidelines; a follow-up study since the guidelines
have been published to determine compliance is planned. The
primary limitation of the systematic review is that only RCTs were
included and no speciﬁc analysis based on surgical procedure was
conducted.
5. Conclusions
In summary, the use of prophylactic antibiotics for plastic sur-
gical procedures at our hospital do not meet recently published
G.-h. Li et al. / International Journal of Surgery 12 (2014) 1300e1305 1305guidelines. Overall, antibiotics were administered too frequently,
the antibiotics administered were not appropriate for the potential
causative organisms, and the timing and duration of administration
were not appropriate. Results of the systematic review also indi-
cated broad variation in the antibiotic administered and in the
timing and dosage administered. Clear, evidence-based guidelines
for the use of prophylactic antibiotics in plastic surgical procedures
are needed.
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